168 related articles for article (PubMed ID: 33150309)
1. Treatment and outcomes of 1041 pediatric patients with neuroblastoma who received multidisciplinary care in China.
Su Y; Qin H; Chen C; Wang S; Zhang S; Zhang D; Jin M; Peng Y; He L; Wang X; Qian S; Qin M; Ge M; Zhang F; Zeng Q; Wang H; Ma X; Ni X
Pediatr Investig; 2020 Sep; 4(3):157-167. PubMed ID: 33150309
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
3. [Clinical characteristics and prognostic analysis of 458 children with high-risk neuroblastoma in a single center].
Su Y; Ma XL; Wang HM; Qin H; Qin MQ; Zhang FQ; Jin M; Zhang DW; Chen CH; Zeng Q; He LJ; Ni X
Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):796-801. PubMed ID: 32987457
[No Abstract] [Full Text] [Related]
4. A Retrospective Analysis of the Therapeutic Outcomes of 117 Neuroblastoma Patients Treated at a Single Pediatric Oncology Center in China.
Yu U; Xu H; Chen S; Yi M; Liu C; Zhang X; Wang C; Song J; Gan Y; Wang J; Wang Y; Zhang Q; Sun J; Xia B; Zhang G; Li C; Wen F; Liu S; Yuan X
Cancer Control; 2023; 30():10732748231187837. PubMed ID: 37575028
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
[No Abstract] [Full Text] [Related]
6. Predictors of survival in patients with high-risk neuroblastoma who failed tandem high-dose chemotherapy and autologous stem cell transplantation.
Yi ES; Son MH; Hyun JK; Cho HW; Ju HY; Lee JW; Yoo KH; Sung KW; Koo HH
Pediatr Blood Cancer; 2020 Feb; 67(2):e28066. PubMed ID: 31736249
[TBL] [Abstract][Full Text] [Related]
7. Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review.
Żebrowska U; Balwierz W; Wechowski J; Wieczorek A
Target Oncol; 2024 Mar; 19(2):143-159. PubMed ID: 38401028
[TBL] [Abstract][Full Text] [Related]
8. Biological features and clinical outcome in infant neuroblastoma: a multicenter experience in Beijing.
Zhang S; Zhang W; Jin M; Sun Q; Zhang Z; Qin H; Su Y; Zhi T; Xie Y; Gao YX; Zhang X; Li L; Liu R; Zhao W; Wang H; Huang D; Ma X
Eur J Pediatr; 2021 Jul; 180(7):2055-2063. PubMed ID: 33580827
[TBL] [Abstract][Full Text] [Related]
9. [Long-term follow-up of neuroblastoma in children less than 18 months of age].
Zhao J; Pan C; Xu M; Zhou M; Gao YJ; Hu WT; Tang JY
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):754-759. PubMed ID: 29050113
[No Abstract] [Full Text] [Related]
10. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; van Dalen EC
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006301. PubMed ID: 26436598
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; Caron HN; van Dalen EC
Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
[TBL] [Abstract][Full Text] [Related]
12. A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients.
Chang HH; Liu YL; Lu MY; Jou ST; Yang YL; Lin DT; Lin KH; Tzen KY; Yen RF; Lu CC; Liu CJ; Peng SS; Jeng YM; Huang SF; Lee H; Juan HF; Huang MC; Liao YF; Lee YL; Hsu WM
Oncotarget; 2017 Jan; 8(3):4360-4372. PubMed ID: 27966455
[TBL] [Abstract][Full Text] [Related]
13. Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma.
De Bernardi B; Conte M; Mancini A; Donfrancesco A; Alvisi P; Tomà P; Casale F; Cordero di Montezemolo L; Cornelli PE; Carli M
J Clin Oncol; 1995 Apr; 13(4):884-93. PubMed ID: 7707115
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group.
Suwannaying K; Monsereenusorn C; Rujkijyanont P; Techavichit P; Phuakpet K; Pongphitcha P; Chainansamit SO; Chotsampancharoen T; Winaichatsak A; Traivaree C; Sathitsamitphong L; Kanjanapongkul S; Komvilaisak P; Sanpakit K; Photia A; Seksarn P; Wiangnon S; Hongeng S;
Pediatr Blood Cancer; 2022 Sep; 69(9):e29757. PubMed ID: 35560972
[TBL] [Abstract][Full Text] [Related]
15. Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.
Park JR; Kreissman SG; London WB; Naranjo A; Cohn SL; Hogarty MD; Tenney SC; Haas-Kogan D; Shaw PJ; Kraveka JM; Roberts SS; Geiger JD; Doski JJ; Voss SD; Maris JM; Grupp SA; Diller L
JAMA; 2019 Aug; 322(8):746-755. PubMed ID: 31454045
[TBL] [Abstract][Full Text] [Related]
16. Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk Neuroblastoma.
Balyasny S; Lee SM; Desai AV; Volchenboum SL; Naranjo A; Park JR; London WB; Cohn SL; Applebaum MA
JAMA Netw Open; 2021 Jul; 4(7):e2116248. PubMed ID: 34236408
[TBL] [Abstract][Full Text] [Related]
17. Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
Bender HG; Irwin MS; Hogarty MD; Castleberry R; Maris JM; Kao PC; Zhang FF; Naranjo A; Cohn SL; London WB
J Clin Oncol; 2023 Jun; 41(17):3149-3159. PubMed ID: 37098238
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of infantile malignant solid tumors in beijing, China: A multicenter 10-year retrospective study.
Jin M; Tian Z; Xie Y; Zhang Z; Li M; Yu Y; Zhang W; Zhao J; Wang H; Zeng Q; Li L; Ge M; Sun N; Zhang X; Gong J; Wu W; Liu R; Zhao W; Huang D; Ma X
Pediatr Investig; 2020 Sep; 4(3):178-185. PubMed ID: 33150311
[TBL] [Abstract][Full Text] [Related]
19. Factors Modifying Outcome After MIBG Therapy in Children With Neuroblastoma-A National Retrospective Study.
Ussowicz M; Wieczorek A; Dłużniewska A; Pieczonka A; Dębski R; Drabko K; Goździk J; Balwierz W; Handkiewicz-Junak D; Wachowiak J
Front Oncol; 2021; 11():647361. PubMed ID: 33912462
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of autologous hematopoietic stem cell transplantation in the treatment of high-risk neuroblastoma in children: a single-center clinical study].
Wang LH; Chen K; Zhang N; Yang JW; Zhang T; Shao JB
Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):476-482. PubMed ID: 37272173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
